Cargando…

Tau in the Pathophysiology of Parkinson’s Disease

The pathological hallmarks of Parkinson's disease (PD) are the progressive loss of dopaminergic neurons in the substantia nigra and the formation of Lewy bodies (LBs) in remaining neurons. LBs primarily consist of aggregated α-Synuclein (α-Syn). However, accumulating evidence suggests that Tau,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Lina, Meng, Lanxia, He, Mingyang, Zhang, Zhentao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585831/ https://www.ncbi.nlm.nih.gov/pubmed/33459970 http://dx.doi.org/10.1007/s12031-020-01776-5

Ejemplares similares

Silica Nanoparticles Promote α-Synuclein Aggregation and Parkinson’s Disease Pathology
por: Yuan, Xin, et al.
Publicado: (2022)

Transgenic Mice Expressing Human α-Synuclein 1-103 Fragment as a Novel Model of Parkinson’s Disease
por: Tian, Ye, et al.
Publicado: (2021)

The Early Events That Initiate β-Amyloid Aggregation in Alzheimer’s Disease
por: Zhang, Xingyu, et al.
Publicado: (2018)

Islet amyloid polypeptide cross-seeds tau and drives the neurofibrillary pathology in Alzheimer’s disease
por: Zhang, Guoxin, et al.
Publicado: (2022)

The γ-Adducin 1–357 fragment promotes tau pathology
por: Yu, Honglu, et al.
Publicado: (2023)

Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer’s disease
por: Zhang, Xingyu, et al.
Publicado: (2023)

The yeast prion protein Sup35 initiates α-synuclein pathology in mouse models of Parkinson’s disease
por: Meng, Lanxia, et al.
Publicado: (2023)

Amphiphysin I cleavage by asparagine endopeptidase leads to tau hyperphosphorylation and synaptic dysfunction
por: Zhang, Xingyu, et al.
Publicado: (2021)

Tau Pathology in Parkinson's Disease
por: Zhang, Xue, et al.
Publicado: (2018)

TREM2 ectodomain and its soluble form in Alzheimer’s disease
por: Yang, Jiaolong, et al.
Publicado: (2020)

Role of dopamine in the pathophysiology of Parkinson’s disease
por: Zhou, Zhi Dong, et al.
Publicado: (2023)

Vulnerabilities in the Tau Network and the Role of Ultrasensitive Points in Tau Pathophysiology
por: Yuraszeck, Theresa M., et al.
Publicado: (2010)

Considerations on the role of environmental toxins in idiopathic Parkinson’s disease pathophysiology
por: Pan-Montojo, Francisco, et al.
Publicado: (2014)

Pathophysiology and Symptomatology of Drooling in Parkinson’s Disease
por: Polychronis, Sotirios, et al.
Publicado: (2022)

An Emerging Role for Phosphoinositides in the Pathophysiology of Parkinson’s Disease
por: Schechter, Meir, et al.
Publicado: (2021)

Gastroparesis in Parkinson Disease: Pathophysiology, and Clinical Management
por: Soliman, Heithem, et al.
Publicado: (2021)

The Pathophysiology of Impulse control Disorders in Parkinson Disease
por: Balarajah, Sharmili, et al.
Publicado: (2013)

Studying the Pathophysiology of Parkinson’s Disease Using Zebrafish
por: Barnhill, Lisa M., et al.
Publicado: (2020)

Gastrointestinal involvement in Parkinson’s disease: pathophysiology, diagnosis, and management
por: Warnecke, T., et al.
Publicado: (2022)

Tau-Reactive Endogenous Antibodies: Origin, Functionality, and Implications for the Pathophysiology of Alzheimer's Disease
por: Hromadkova, Lenka, et al.
Publicado: (2019)

Imaging tau pathology in Parkinsonisms
por: Coakeley, Sarah, et al.
Publicado: (2017)

Dysfunction of Synaptic Vesicle Endocytosis in Parkinson’s Disease
por: Zou, Li, et al.
Publicado: (2021)

Parkinson's Disease: New Insights into Pathophysiology and Rehabilitative Approaches
por: Frisardi, Vincenza, et al.
Publicado: (2016)

New Understanding on the Pathophysiology and Treatment of Constipation in Parkinson’s Disease
por: Xu, Jianli, et al.
Publicado: (2022)

Tremor in Parkinson’s Disease: From Pathophysiology to Advanced Therapies
por: Abusrair, Ali H., et al.
Publicado: (2022)

Genetic Insights into the Molecular Pathophysiology of Depression in Parkinson’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

Circulating Inflammatory miRNAs Associated with Parkinson’s Disease Pathophysiology
por: Oliveira, Sara R., et al.
Publicado: (2020)

A Tangled Web – Tau and Sporadic Parkinson's Disease
por: Wray, Selina, et al.
Publicado: (2010)

Diagnostic and Pathophysiological Impact of Myocardial MIBG Scintigraphy in Parkinson's Disease
por: Spiegel, Jörg
Publicado: (2009)

A synapsin Ⅰ cleavage fragment contributes to synaptic dysfunction in Alzheimer's disease
por: Meng, Lanxia, et al.
Publicado: (2022)

Pathophysiological Mechanisms of Antipsychotic-Induced Parkinsonism
por: Vaiman, Elena E., et al.
Publicado: (2022)

Untangling Tau: Molecular Insights into Neuroinflammation, Pathophysiology, and Emerging Immunotherapies
por: Davidson, Ryder, et al.
Publicado: (2023)

Tubulin and Tau: Possible targets for diagnosis of Parkinson’s and Alzheimer’s diseases
por: Salama, Mohamed, et al.
Publicado: (2018)

Role and Mechanism of Vitamin A Metabolism in the Pathophysiology of Parkinson’s Disease
por: Marie, Anaıs, et al.
Publicado: (2021)

Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson’s Disease?
por: Schulz-Schaeffer, Walter J.
Publicado: (2015)

Apathy in Parkinson’s Disease: Diagnosis, Neuropsychological Correlates, Pathophysiology and Treatment
por: Santangelo, Gabriella, et al.
Publicado: (2013)

Unraveling Pathophysiological Mechanisms of Parkinson’s Disease: Contribution of CSF Biomarkers
por: Farotti, Lucia, et al.
Publicado: (2020)

Freezing of gait in Parkinson’s disease: pathophysiology, risk factors and treatments
por: Gao, Chao, et al.
Publicado: (2020)

Monogenic Parkinson’s Disease: Genotype, Phenotype, Pathophysiology, and Genetic Testing
por: Jia, Fangzhi, et al.
Publicado: (2022)

Neuroinflammation and Mitochondrial Dysfunction in Parkinson’s Disease: Connecting Neuroimaging with Pathophysiology
por: Pizarro-Galleguillos, Benjamin Matís, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j58irhkpo83qflh7lh3oljngc8